urapidil has been researched along with Pregnancy in 15 studies
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urapidil proved to be equally effective as dihydralazine in lowering BP in patients with pre-eclampsia, but showed a better controllability and tolerability." | 9.12 | Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. ( Bartz, C; Briese, V; Heilmann, L; Hopp, H; Schauf, B; Wacker, JR; Wagner, BK, 2006) |
| "Since urapidil decreased the high blood pressure in patients with pre-eclampsia without serious side-effects urapidil appears preferable superior to dihydralazine." | 9.08 | Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. ( Bastert, G; Wacker, J; Walter-Sack, I; Werner, P, 1998) |
| "To evaluate the efficacy and tolerance of injectable urapidil (Eupressyl(®)) for the treatment of severe pregnancy-associated arterial hypertension." | 7.78 | [Use of injectable urapidil in pregnancy-induced hypertension and preeclampsia]. ( Alassas, N; Carles, G; Dallah, F; Helou, J; Ibrahim, N; Youssef, M, 2012) |
| "Urapidil is a potent antihypertensive drug that has been in clinical use for more than 20 years." | 5.35 | Neonatal transient respiratory depression after maternal urapidil infusion for hypertension. ( Allegaert, K; Hanssens, M; Vanhaesebrouck, S, 2009) |
| "treatment with urapidil at a diastolic blood pressure of more than 100 mm Hg." | 5.29 | [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil]. ( Bastert, G; Grischke, EM; Müller, J; Unkels, R; Wacker, J, 1994) |
| "Urapidil proved to be equally effective as dihydralazine in lowering BP in patients with pre-eclampsia, but showed a better controllability and tolerability." | 5.12 | Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. ( Bartz, C; Briese, V; Heilmann, L; Hopp, H; Schauf, B; Wacker, JR; Wagner, BK, 2006) |
| "Since urapidil decreased the high blood pressure in patients with pre-eclampsia without serious side-effects urapidil appears preferable superior to dihydralazine." | 5.08 | Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. ( Bastert, G; Wacker, J; Walter-Sack, I; Werner, P, 1998) |
| "To evaluate the efficacy and tolerance of injectable urapidil (Eupressyl(®)) for the treatment of severe pregnancy-associated arterial hypertension." | 3.78 | [Use of injectable urapidil in pregnancy-induced hypertension and preeclampsia]. ( Alassas, N; Carles, G; Dallah, F; Helou, J; Ibrahim, N; Youssef, M, 2012) |
| " These drugs must be administered parenterally and have a half-life of only a few minutes." | 2.40 | Clinical pharmacokinetics of vasodilators. Part II. ( Heintz, B; Kirsten, D; Kirsten, R; Nelson, K, 1998) |
| "A causal treatment of preeclampsia is, with the exception of delivery, not possible up to now." | 2.40 | [Current aspects of antihypertensive therapy in pregnant patients with pre-eclampsia]. ( Bastert, G; Henschel, B; Schulz, M; Wacker, J; Werner, P, 1999) |
| "To investigate the diagnosis and treatment of pheochromocytoma during pregnancy." | 1.40 | Diagnosis and treatment of pheochromocytoma during pregnancy. ( Dong, D; Li, H, 2014) |
| "Urapidil is a potent antihypertensive drug that has been in clinical use for more than 20 years." | 1.35 | Neonatal transient respiratory depression after maternal urapidil infusion for hypertension. ( Allegaert, K; Hanssens, M; Vanhaesebrouck, S, 2009) |
| "treatment with urapidil at a diastolic blood pressure of more than 100 mm Hg." | 1.29 | [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil]. ( Bastert, G; Grischke, EM; Müller, J; Unkels, R; Wacker, J, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, D | 1 |
| Li, H | 1 |
| Minushkina, LO | 1 |
| Diemunsch, P | 1 |
| Garcia, V | 1 |
| Lyons, G | 1 |
| Pottecher, J | 1 |
| Emmanuel, S | 1 |
| Carles, G | 1 |
| Helou, J | 1 |
| Dallah, F | 1 |
| Ibrahim, N | 1 |
| Alassas, N | 1 |
| Youssef, M | 1 |
| Wacker, JR | 1 |
| Wagner, BK | 1 |
| Briese, V | 1 |
| Schauf, B | 1 |
| Heilmann, L | 1 |
| Bartz, C | 1 |
| Hopp, H | 1 |
| Vanhaesebrouck, S | 1 |
| Hanssens, M | 1 |
| Allegaert, K | 1 |
| Wacker, J | 6 |
| Müller, J | 1 |
| Grischke, EM | 1 |
| Unkels, R | 1 |
| Bastert, G | 6 |
| Lewicka, S | 1 |
| Haack, D | 1 |
| Takenaka, Y | 1 |
| Toyoda, N | 1 |
| Werner, P | 2 |
| Walter-Sack, I | 1 |
| Kirsten, R | 1 |
| Nelson, K | 1 |
| Kirsten, D | 1 |
| Heintz, B | 1 |
| Schiesser, M | 1 |
| Zafiriou, N | 1 |
| Schulz, M | 3 |
| Henschel, B | 1 |
| Pastor Tomás, EM | 1 |
| Vaquerizo Gareta, A | 1 |
| Hernández Elía, R | 1 |
| Sanz López, A | 1 |
| Cuartero Lobera, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Severe Hypertension During Pre-Eclampsia.A Preliminary Equivalence Study Between URAPIDIL and NICARDIPINE[NCT00409253] | Phase 3 | 72 participants (Anticipated) | Interventional | 2007-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for urapidil and Pregnancy
| Article | Year |
|---|---|
[Treatment of hypertensive emergencies and malignant hypertension: the possibility of using urapidil].
Topics: Antihypertensive Agents; Emergency Treatment; Female; Humans; Hypertension, Malignant; Piperazines; | 2014 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilo | 1998 |
[Current aspects of antihypertensive therapy in pregnant patients with pre-eclampsia].
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Dihydralazine; Female; Humans; In | 1999 |
4 trials available for urapidil and Pregnancy
| Article | Year |
|---|---|
Urapidil versus nicardipine in preeclamptic toxaemia: A randomised feasibility study.
Topics: Antihypertensive Agents; Blood Pressure; Feasibility Studies; Female; Humans; Infant, Newborn; Nicar | 2015 |
Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dihydralazine; Dose-Response Relationship, Drug; Fem | 2006 |
Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diastole; Dihydralazine; Female; Heart Rate; Humans; | 1998 |
[Effect of Urapidil in antihypertensive therapy of preeclampsia on newborns].
Topics: Adult; Antihypertensive Agents; Cardiovascular Physiological Phenomena; Dihydralazine; Dose-Response | 2001 |
8 other studies available for urapidil and Pregnancy
| Article | Year |
|---|---|
Diagnosis and treatment of pheochromocytoma during pregnancy.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Blood Pressure; Female; Humans; Laparoscopy; Phenoxyb | 2014 |
[Use of injectable urapidil in pregnancy-induced hypertension and preeclampsia].
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adult; Antihypertensive Agents; Female; Gestati | 2012 |
Neonatal transient respiratory depression after maternal urapidil infusion for hypertension.
Topics: Adult; Antihypertensive Agents; Cesarean Section; Dose-Response Relationship, Drug; Female; Humans; | 2009 |
[Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitors; Dihydralazine; Drug Administration | 1994 |
Hypertension in pregnancy.
Topics: Antihypertensive Agents; Blood Pressure Determination; Female; Humans; Hypertension; Leukocytes, Mon | 1993 |
The effect of alpha 1-blocking vasodilator on fetal growth and uteroplacental blood flow in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Embryonic and Fetal Development; Female; Fetal Blood; Feta | 1995 |
[Doppler ultrasound findings in therapy with urapidil].
Topics: Adult; Antihypertensive Agents; Female; Fetus; Humans; Hypertension; Infant, Newborn; Infusions, Int | 1999 |
[Pre-eclampsia and treatment with urapidil].
Topics: Adult; Antihypertensive Agents; Cesarean Section; Female; Humans; Piperazines; Pre-Eclampsia; Pregna | 1999 |